Collaborative Neuroscience Research, LLC
Quick facts
Marketed products
- Xanomeline and Trospium Chloride · Psychiatry / Neurology
Xanomeline is a muscarinic M1/M4 receptor agonist combined with trospium chloride, an anticholinergic agent, to enhance cognitive function while mitigating peripheral cholinergic side effects.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Collaborative Neuroscience Research, LLC portfolio CI brief
- Collaborative Neuroscience Research, LLC pipeline updates RSS
Frequently asked questions about Collaborative Neuroscience Research, LLC
What are Collaborative Neuroscience Research, LLC's marketed drugs?
Top marketed products include Xanomeline and Trospium Chloride.
Related
- Xanomeline and Trospium Chloride · Psychiatry / Neurology
- Sector hub: All tracked pharma companies